网站综合信息 www.zensun.com
- 标题:
- Zensun (Shanghai) Sci & Tech Co., Ltd.
- 关键字:
- Zensun 泽生 科技 zensun (shanghai) 上海泽生 zensun tech. Neuregulin Neucar
- 描述:
- Zensun (Shanghai) Sci& Tech Co., Ltd. is a biopharmaceutical company focused on the development
- 域名信息
- 域名年龄:23年10个月22天 注册日期:2001年08月17日 到期时间:2015年08月17日
注册商:HICHINA ZHICHENG TECHNOLOGY LTD.
- 服务器空间
- IP:203.135.133.90 同IP网站7个 详情
地址:香港 特别行政区
- 备案信息
- 备案号:沪ICP备06030993号 审核时间:2013-05-02 详情
主办单位:上海泽生科技开发有限公司 性质:企业
网站名:上海泽生科技开发有限公司 首页网址:www.zensun.com
域名流量Alexa排名
域名注册Whois信息
zensun.com
域名年龄: 23年10个月22天注册时间: 2001-08-17
到期时间: 2015-08-17
注 册 商: HICHINA ZHICHENG TECHNOLOGY LTD.
获取时间: 2014年09月22日 21:47:33
Domain Name: ZENSUN.COM
Registrar: HICHINA ZHICHENG TECHNOLOGY LTD.
Whois Server: grs-whois.hichina.com
Referral URL: http://www.net.cn
Name Server: DNS13.HICHINA.COM
Name Server: DNS14.HICHINA.COM
Status: ok
Updated Date: 2014-08-06
Creation Date: 2001-08-17
Expiration Date: 2015-08-17
>>> Last update of whois database: Mon, 2014-Sep-22 13:50:00 UTC <<<
网站头文件(HTTP Header)
HTTP/1.1 200 OK 访问时间:2014年10月11日 10:14:34 服务器:Microsoft-IIS/6.0 语言环境:ASP.NET ASP.NET版本:4.0.30319 设置Cookie:ASP.NET_SessionId=1thvbsdu2ilhe0lwjnvre2iv; path=/; HttpOnly 缓存控制:private 类型:text/html; charset=utf-8 文件大小:15495 网站编码:utf-8
同IP网站(同服务器)
其他后缀域名
网站首页快照(纯文字版)
抓取时间:2014年10月11日 10:15:43
网址:http://www.zensun.com/
标题:Zensun (Shanghai) Sci & Tech Co., Ltd.
关键字:Zensun, 泽生，科技，zensun (shanghai), 上海泽生，zensun tech., Neuregulin, Neucardin, NRG-1, rhNRG-1, biopharmaceutical, recombinan
描述:Zensun (Shanghai) Sci& Tech Co., Ltd. is a biopharmaceutical company focused on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threat
主体:
网址:http://www.zensun.com/
标题:Zensun (Shanghai) Sci & Tech Co., Ltd.
关键字:Zensun, 泽生，科技，zensun (shanghai), 上海泽生，zensun tech., Neuregulin, Neucardin, NRG-1, rhNRG-1, biopharmaceutical, recombinan
描述:Zensun (Shanghai) Sci& Tech Co., Ltd. is a biopharmaceutical company focused on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threat
主体:
Newsroom Zensun Announces Successful End of Phase 2 Meeting for Neucardin™ SHANGHAI, CHINA and SAN DIEGO, USA, January 4, 2014 – Zensun (Shanghai) Sci. & Tech., Ltd, and its subsidiary Zensun USA, Inc. are pleased to announce the successful completion of an End of Phase 2 (EOP2) Meeting for Neucardin™, an innovative “first-in-class” anti-heart failure drug. Based on the results of the meeting, Zensun believes that they have a clear path to the pivotal Phase 3 program to support a Biologic License Application (BLA) in the U.S, and now Zensun is going to start all necessary preparations for the initiation of the Phase 3 study. close HOME 中文版 ENGLISH | ZENSUN USA HOMEHOME ABOUT ZENSUNABOUT ZENSUN Introduction Management Team Scientific Advisory Board Patent Lawyer NEWSROOMNEWSROOM Press Release Media SCIENCESCIENCE Our Science Neucardin rhErbB3-f Publications Intellectual Properties PIPELINEPIPELINE Overview Neucardin rhErbB3-f ZS03 ZS04 ZS05 Clinical Trials Patient Enrolling CAREERSCAREERS Careers CONTACT USCONTACT US Anti-Heart Failure Drug recombinant human neuregulin-1(NEUCARDIN : rhNRG-1) Chronic heart failure (CHF) is the final stage of many cardiovascular diseases and its incidence is increasing globally.It is estimated... Healing the Heart Forbes China interviewed Zensun’s CEO - Dr. Mingdong Zh... 01/04/2014Zensun Announces Successful End ... 05/29/2013Zensun Announces Positive Result... 02/21/2013Zensun Obtained the Exciting Res... Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focused on the development of innovative bio-therapeutic ... ABOUT ZENSUN | NEWSROOM | SCIENCE | PIPELINE | CAREERS | CONTACT US Address : No. 68 Ju LI Road, Zhangjiang Hi-tech Park, Shanghai, PR.China （沪ICP备06030993号） Tel : 86-21-50802627 Fax : 86-21-50802621
最近查询网站